We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Updated Draft Guidance on Initial Pediatric Studies
FDA Issues Updated Draft Guidance on Initial Pediatric Studies
Sponsors that fail to address all pediatric age groups or indications in their initial pediatric study plans would have 30 days to address any deficiencies and submit a new plan, FDA says.